Stocks

A special shareholder meeting is slated for March 8

The products are set for wide distribution through the country's pharmacy network

No explanation has yet been given for the move

With adult-use sales halved from a year ago, the large majority of the firm's sales now come from international medical markets

It also revealed an expanded deal with an unnamed licensed producer

Taking a recent majority stake in a baby food maker, Neptune joins other pot firms expanding broadly into different CPG categories

The firm had said it plans to cut SG&A expenses by 30% by the end of fiscal 2023

But sales for the firm's BioSteel sports drinks and Storz & Bickel vaporizers have been rising

The distribution agreement puts craft beers in restaurants, bars, grocery chains and liquor stores across the Golden State

The firm says it commands 30% of the country's medical cannabis market

The firm says Canadian patients will get broader access to its products, as it continues to push for international growth

The company is awaiting approval of an import permit

The firm says the move will have no material impact on its cultivation or processing capabilities

In partnership with Shawanaga First Nation, a plan aims to provide access even to remote communities

The pot platform is trading under LFLY after merging with Merida Merger Corp. I

The company plans to add 20 franchise stores this year

The debt is secured by mortgages on the firm's physical assets

The new VPs will oversee marketing, sales, finance and strategy

In December, the firm finished a public offering for proceeds of $3.2 million

The firm says Adam Arviv's 'actions serve as an unhelpful distraction'

After being hit with impairment charges, the firm posted a Q4 net loss of $4.2M

Patients are being encouraged to transfer to Mendo Cannabis

The firm launched its first beverage with hemp in Germany last April

The sports drink is being stocked in more than 20 grocery, convenience and drug store chains across the country

The firm has been given 180 days to improve its share price

The expanded debt funding follows the firm's US$2.1-billion acquisition of former rival Harvest Health last year

It's also launching a new CBD brand with an artisanal hemp producer

The grand opening is Saturday at 278A Queen St. West

Due to 'personnel challenges' the firm has yet to finalize its income tax provision, but expects to do so on or by Jan. 31

The first brands offered through the platform include Auxly, Aleafia, Cronos Group, FIGR and Wagners

Stock will start trading at market open Thursday under the symbol NUMIF

The company says it's using learnings from operations in Germany to better meet patient needs

Expenses were down 71% but the firm still reported a $5.4-million loss

The firm reported its third-straight quarter of positive adjusted EBITDA

The firm has sold its 25% interest in Belleville Complex Inc. for $10.1 million

Ongoing shipments to Focus Medical suggest a high demand for premium flower in the country

GNC has over 4,800 retail locations across America

The firm expects the proceeds and funds from operations to be enough to repay its convertible debentures on maturity

If approved, it will mark the firm's first independent clinical trial with a proprietary extract